Emergent BioSolutions begins phase 3 trial of CHIKV VLP vaccine candidate

Emergent BioSolutions said that it has dosed the first participant in a phase 3 clinical trial of CHIKV VLP — the company’s single-dose chikungunya vaccine ... Read More